Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2020
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
Zia Khan, Flavia Di Nucci, Antonia Kwan, et al.
Cancer
|
March 5, 2013
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
Matthew D Galsky, Ryan Hendricks, Robert Svatek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2019
Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results
Padmanee Sharma, Arlene Siefker-Radtke, Filippo de Braud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Cancer Medicine
|
February 28, 2015
HER2 as a target in invasive urothelial carcinoma
Joaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Cancer Cell
|
November 22, 2024
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
Habib Hamidi, Yasin Senbabaoglu, Niha Beig, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Eva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Mahul B Amin, Eva Comperat, Jonathan I Epstein, et al.
Genome Medicine
|
June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
Dana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2020
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
Zia Khan, Flavia Di Nucci, Antonia Kwan, et al.
Cancer
|
March 5, 2013
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
Matthew D Galsky, Ryan Hendricks, Robert Svatek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2019
Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results
Padmanee Sharma, Arlene Siefker-Radtke, Filippo de Braud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2020
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Jonathan Rosenberg, Srikala S Sridhar, Jingsong Zhang, et al.
Cancer Medicine
|
February 28, 2015
HER2 as a target in invasive urothelial carcinoma
Joaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Cancer Cell
|
November 22, 2024
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
Habib Hamidi, Yasin Senbabaoglu, Niha Beig, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Eva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Advances in Anatomic Pathology
|
June 15, 2021
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia
Mahul B Amin, Eva Comperat, Jonathan I Epstein, et al.
Genome Medicine
|
June 1, 2021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
Dana W Y Tsui, Michael L Cheng, Maha Shady, et al.
Page
of 8